| NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
| 641 Västerbotten |
| Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
| Benign sample | 528 | 4.5% | 28 | 0.2% | 6 | 0.1% | 1 | 0.0% | 1 | 0.0% | 4 | 0.0% | 11042 | 95.1% | 11610 | 100.0% |
| ASCUS | 239 | 35.4% | 73 | 10.8% | 30 | 4.4% | 1 | 0.1% | . | . | 1 | 0.1% | 332 | 49.1% | 676 | 100.0% |
| LSIL | 188 | 32.3% | 161 | 27.7% | 64 | 11.0% | . | . | . | . | 1 | 0.2% | 168 | 28.9% | 582 | 100.0% |
| Atypical glandular cells/AGC | 12 | 44.4% | 1 | 3.7% | 4 | 14.8% | 2 | 7.4% | 2 | 7.4% | . | . | 6 | 22.2% | 27 | 100.0% |
| Unclear atypia | 13 | 54.2% | . | . | 5 | 20.8% | . | . | . | . | 1 | 4.2% | 5 | 20.8% | 24 | 100.0% |
| ASC-H | 28 | 24.8% | 20 | 17.7% | 60 | 53.1% | 1 | 0.9% | 1 | 0.9% | . | . | 3 | 2.7% | 113 | 100.0% |
| HSIL | 14 | 9.3% | 6 | 4.0% | 123 | 81.5% | 1 | 0.7% | 4 | 2.6% | 1 | 0.7% | 2 | 1.3% | 151 | 100.0% |
| Suspected Adenocarcinom | . | . | . | . | . | . | 1 | 25.0% | 1 | 25.0% | . | . | 2 | 50.0% | 4 | 100.0% |
| Squamous cell cancer | . | . | . | . | . | . | . | . | 5 | 71.4% | 2 | 28.6% | . | . | 7 | 100.0% |
| Totalt | 1022 | 7.7% | 289 | 2.2% | 292 | 2.2% | 7 | 0.1% | 14 | 0.1% | 10 | 0.1% | 11560 | 87.6% | 13194 | 100.0% |
| NOTE: Histopathological outcome from T83x taken into account. |
| This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
| * Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
| The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
| Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
| Snomed codes in the category Cancer: |
|---|
| M80703, M81403, M83806 |